{"0f72865d-fe3e-4163-918f-27e7c84781c3": "FDA's approval means that cefiderocol, sold under the brand name Fetroja, can be used to treat patients who have hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by gram-negative pathogens. The antibiotic was initially approved for treatment of complicated urinary tract infections.", "8e258b49-53ff-4566-8088-a5161e4a62cc": "FDA Approves Cefiderocol for Hospital-Acquired, Ventilator-Associated Pneumonia"}